HER2-Negative Breast Cancer Active Not Recruiting Phase 2 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0072181 (HER2-Negative Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00618657Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant SettingTreatment
NCT01818063Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast CancerTreatment
NCT01372579Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer PatientsTreatment